The Medical Republic

The Medical Republic

The Medical Republic is a community of doctors, journalists, and traditional publishers who aim to enhance communication for healthcare professionals in today's mobile and social world. We understand that the healthcare landscape is evolving, and with change comes challenges. Our goal is to assist in navigating these changes, even if it means addressing topics that may be uncomfortable for some. We believe that through these discussions, we can drive progress. Our ultimate mission is to improve community health by supporting connected primary caregivers and empowering patients.

National, Trade/B2B
English
Magazine

Outlet metrics

Domain Authority
46
Ranking

Global

#602981

Australia

#22142

Health/Health

#353

Traffic sources
Monthly visitors

Articles

  • 1 day ago | medicalrepublic.com.au | Grant Holloway

    Could this be a solution to the UCC staffing dilemma? Back in the late 1970s, your Back Page scribbler studied a book called “In the Shadow of Man” by Dr Jane Goodall, which detailed how chimpanzees in the wild would fashion and modify natural objects to use as tools. This was groundbreaking because, at the time, most folks thought tool-making in this sophisticated sense was something only humans got up to.

  • 2 days ago | medicalrepublic.com.au | Talia Meyerowitz-Katz

    Username Password Full Name LEAVE THIS BLANK What field do you work in?

  • 4 days ago | medicalrepublic.com.au | Ruby Prosser Scully

    Testing blood eosinophils at admission could have ‘significant prognostic implications’, say researchers. Elderly COPD patients with a blood eosinophil count of 150 cells/μL or more on admission to hospital for covid are significantly more likely to develop respiratory and systemic complications than those without COPD.

  • 4 days ago | medicalrepublic.com.au | Ruby Prosser Scully

    Tirzepatide shows substantial reductions in weight and waist circumference reductions in a comparison trial with semaglutide. Tirzepatide (Mounjaro, Eli Lilly) may surpass semaglutide (Wegovy, Novo Nordisk) for weight loss in patients with obesity and no diabetes, according to new research in the NEJM.

  • 4 days ago | medicalrepublic.com.au | Penny Durham

    The true rates may be much higher than current Australian data suggests – especially for type 2 diabetes. Rates of diabetes in Australia, especially type 2, are substantially higher than estimated thanks to under-enrolment in the national registry. A team led by Emma Cox from the School of Public Health at Sydney University developed an algorithm to more accurately assess the burden of diabetes in NSW by using linked administrative data.

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

Email Patterns

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations